article thumbnail

$609.8 Million Worldwide Recombinant DNA Technology Industry to 2027 – Impact of COVID-19 on the Market – ResearchAndMarkets.com

BioTech 365

Million Worldwide Recombinant DNA Technology Industry to 2027 – Impact of COVID-19 on the Market – ResearchAndMarkets.com $609.8 Million Worldwide Recombinant DNA Technology Industry to 2027 – Impact of COVID-19 on the Market – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Recombinant DNA … Continue reading → Business Wire

article thumbnail

Sanofi/GSK restart COVID-19 vaccine trials after tweaking formulation

Pharma Phorum

The vaccine is based around an adjuvanted recombinant protein, which will be tested in a new phase 2 study to assess the response including in older adults.

article thumbnail

TAKHZYRO® (lanadelumab) for Hereditary Angioedema Patients to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress

The Pharma Data

TAKHZYRO is produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology. Analysis of Safety and Efficacy for up to 2.5